BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32929842)

  • 1. TET2 promotes anti-tumor immunity by governing G-MDSCs and CD8
    Li S; Feng J; Wu F; Cai J; Zhang X; Wang H; Fetahu IS; Iwanicki I; Ma D; Hu T; Liu H; Wang B; Shi G; Tan L; Shi YG
    EMBO Rep; 2020 Oct; 21(10):e49425. PubMed ID: 32929842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer.
    Su L; Zhang F; Liu MX; Li H; Li Q; Zhu YZ; Hou YF; Chen X; Wang XY; Qian CM; Yao C; Wang LX; Jiao XN; Zhu XD; Xu ZH; Zou CP
    J Ethnopharmacol; 2023 Sep; 313():116491. PubMed ID: 37072091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.
    Pan W; Zhu S; Qu K; Meeth K; Cheng J; He K; Ma H; Liao Y; Wen X; Roden C; Tobiasova Z; Wei Z; Zhao J; Liu J; Zheng J; Guo B; Khan SA; Bosenberg M; Flavell RA; Lu J
    Immunity; 2017 Aug; 47(2):284-297.e5. PubMed ID: 28813659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin inhibits the progression of bladder cancer by selectively depleting G-MDSCs: A novel chemoimmunomodulating strategy.
    Wu K; Tan MY; Jiang JT; Mu XY; Wang JR; Zhou WJ; Wang X; Li MQ; He YY; Liu ZH
    Clin Immunol; 2018 Aug; 193():60-69. PubMed ID: 29410331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.
    Sahraei M; Bose M; Sanders JA; De C; DasRoy L; Nath S; Brouwer CR; Mukherjee P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane activates CD8
    Liu J; Chen H; Guo C; Li J; Li M; Zhao M; Fu Z; Zhang Z; Li F; Zhao X; Yang L; Wang L; Lv Q; Zhang Y
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38296593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1beta triggers the expansion of circulating granulocytic myeloid-derived suppressor cell subset dependent on Erk1/2 activation.
    Shi H; Qin Y; Tian Y; Wang J; Wang Y; Wang Z; Lv J
    Immunobiology; 2022 Jan; 227(1):152165. PubMed ID: 34936966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.
    Tengesdal IW; Menon DR; Osborne DG; Neff CP; Powers NE; Gamboni F; Mauro AG; D'Alessandro A; Stefanoni D; Henen MA; Mills TS; De Graaf DM; Azam T; Vogeli B; Palmer BE; Pietras EM; DeGregori J; Tan AC; Joosten LAB; Fujita M; Dinarello CA; Marchetti C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Lim HX; Choi S; Cho D; Kim TS
    Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.
    Cao Y; Feng Y; Zhang Y; Zhu X; Jin F
    BMC Cancer; 2016 Jun; 16():343. PubMed ID: 27246354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor-infiltrating Ly6G
    Chang CJ; Yang YH; Chiu CJ; Lu LC; Liao CC; Liang CW; Hsu CH; Cheng AL
    Int J Cancer; 2018 May; 142(9):1878-1889. PubMed ID: 29266245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.
    Jayakumar A; Bothwell ALM
    Neoplasia; 2017 Aug; 19(8):595-605. PubMed ID: 28654863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    Wang Y; Schafer CC; Hough KP; Tousif S; Duncan SR; Kearney JF; Ponnazhagan S; Hsu HC; Deshane JS
    J Immunol; 2018 Jul; 201(1):278-295. PubMed ID: 29752311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8
    Zhang Md J; Zhang Md L; Yang Md Y; Liu Md Q; Ma Md H; Huang Md A; Zhao Md Y; Xia Md Z; Liu Md T; Wu Md G
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1533-1546. PubMed ID: 33238192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the functions of myeloid-derived suppressor cells : a new strategy of hydrogen sulfide anti-cancer effects.
    De Cicco P; Ercolano G; Rubino V; Terrazzano G; Ruggiero G; Cirino G; Ianaro A
    Br J Pharmacol; 2020 Feb; 177(4):884-897. PubMed ID: 31392723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Yan D; Zhang M; Wang L; Adeshakin FO; Liu W; Wan X
    Biochem Biophys Res Commun; 2020 Feb; 522(3):604-611. PubMed ID: 31785814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.
    Xie Z; Ikegami T; Ago Y; Okada N; Tachibana M
    Oncoimmunology; 2020; 9(1):1734268. PubMed ID: 32158627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.